Headquartered in Waltham, Massachusetts, we develop and deliver innovative medicines for complex yet under-treated health conditions across a range of therapeutic areas including anemia, pregnancy complications, womenâs sexual function and menopause-related issues. We also work with patients and healthcare experts to break down barriers to care for the communities we serve through focused education and support programs. We invest in promising therapies at various stages of development and advance them through the clinical and regulatory process to deliver new treatment options to patients. Source
No articles found.
Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthro...
Eyenovia is a late-stage ophthalmic biopharmace...
Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission...
Teligent is a specialty generic pharmaceutical ...
Community Ventures is a non-profit organization that fosters local community econo...
Community Ventures is a non-profit organization...
Trevena is a biopharmaceutical company focused on the development and commercializ...
Trevena is a biopharmaceutical company focused ...
Midatech is an international specialty pharmaceutical company focused on the devel...
Midatech is an international specialty pharmace...
Selecta Biosciences, Inc. is a clinical-stage biotechnology company focused on unl...
Selecta Biosciences, Inc. is a clinical-stage b...
FibroGen, Inc. is a leading science-based biopharmaceutical company discovering an...
FibroGen, Inc. is a leading science-based bioph...
Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women's in...
Viveve, Inc., the wholly owned subsidiary of Vi...
Join the National Investor Network and get the latest information with your interests in mind.